1. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. (January 2022) Authors: Mariette, Xavier; Hermine, Olivier; Tharaux, Pierre-Louis; Resche-Rigon, Matthieu; Porcher, Raphael; Ravaud, Philippe; Bureau, Serge; Dougados, Maxime; Tibi, Annick; Azoulay, Elie; Cadranel, Jacques; Emmerich, Joseph; Fartoukh, Muriel; Guidet, Bertrand; Humbert, Marc; Lacombe, Karine; Mahevas, Ma... Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Issue 3 (March 2021) Authors: Mariette, Xavier; Hermine, Olivier; Resche-Rigon, Matthieu; Porcher, Raphael; Ravaud, Philippe; Bureau, Serge; Dougados, Maxime; Tibi, Annick; Azoulay, Elie; Cadranel, Jacques; Emmerich, Joseph; Fartoukh, Muriel; Guidet, Bertrand; Humbert, Marc; Lacombe, Karine; Mahevas, Matthieu; Pene, Frédéric;... Journal: Lancet Issue: Volume 9:Issue 3(2021) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗